Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY
European Journal of Heart Failure · 2025
DOI: 10.1002/ejhf.3797 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, 2025. Verfasst von Gregor Heitzinger und 51 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Stroke Volume, Tricuspid Valve Insufficiency, Registries, Ventricular Function, Left. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Aims
The impact of treatment for tricuspid regurgitation (TR) across different levels of left ventricular ejection fraction (LVEF) remains uncertain. This study aimed to compare the outcomes of surgical and transcatheter tricuspid valve interventions (TTVI) to conservative (medical) management across LVEF categories. Methods and results Patients with severe isolated TR from the TRIGISTRY, a multicentre international registry, were categorized based on LVEF (preserved ejection fraction [pEF]: ≥50%, mildly reduced ejection fraction [mrEF]: 41–49%, and reduced ejection fraction [rEF]: ≤40%). We assessed the impact of treatment modality and procedural success (mild-to-moderate or lower residual TR) on 2-year survival within each LVEF category. Among 2384 patients, 1383 had pEF, 400 had mrEF, and 601 had rEF. Compared to conservative management, surgery (p < 0.0005) and TTVI (p < 0.0001) were associated with a survival benefit in patients with pEF. No significant survival advantage was observed in patients with mrEF (p = 0.28 for both), nor in those with rEF (p = 0.76 and p = 0.22, respectively). Similar results were obtained when surgical and transcatheter interventions were grouped (p < 0.0001, p = 0.17 and p = 0.29 in patients with pEF, mrEF and rEF, respectively). Patients with residual TR after TTVI exhibited a trend toward worse survival compared to those managed conservatively across all LVEF categories (p = 0.47, p = 0.33 and p = 0.008 in pEF, mrEF and rEF, respectively).
Conclusions
Transcatheter tricuspid valve intervention, whether surgical or transcatheter-based, was associated with improved survival in patients with pEF but not in those with mrEF or rEF. Residual TR remained a significant prognostic factor across the entire LVEF spectrum. These findings highlight the need for careful patient selection when considering TTVI in individuals with rEF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, Austria.
- Department of Cardiology, Centre Cardiologique du Nord, Saint-Denis, France.
- Department of Cardiology, Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv, Israel.
- Cardiovascular Disease Department, Mayo Clinic, Rochester, MN, USA.
- Section of Cardiology, Department of Medicine, University of Verona, Verona, Italy.
- Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: David Messika-Zeitoun
Zitieren
APA
Heitzinger, G., Dreyfus, J., Dannenberg, V., Topilsky, Y., Benfari, G., Marsan, N. A., Taramasso, M., Russo, G., Bohbot, Y., Iliadis, C., Weber, M., Nombela-Franco, L., Eixerés-Esteve, A., Bazire, B., Iung, B., Obadia, J. F., Loureiro, R. E., Riant, E., Donal, E., …, & TRIGISTRY Investigators (2025). Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3797
Vancouver
Heitzinger G, Dreyfus J, Dannenberg V, Topilsky Y, Benfari G, Marsan NA, et al. Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY. European Journal of Heart Failure. 2025. doi:10.1002/ejhf.3797
BibTeX
@article{Heitzinger2025,
author = {Heitzinger, Gregor and Dreyfus, Julien and Dannenberg, Varius and Topilsky, Yan and Benfari, Giovanni and Marsan, Nina Ajmone and Taramasso, Maurizio and Russo, Giulio and Bohbot, Yohann and Iliadis, Christos and Weber, Marcel and Nombela-Franco, Luis and Eixerés-Esteve, Andrea and Bazire, Baptiste and Iung, Bernard and Obadia, Jean-François and Loureiro, Rodrigo Estevez and Riant, Elisabeth and Donal, Erwan and Habib, Gilbert and Lavie-Badie, Yoan and Hausleiter, Jörg and Stolz, Lukas and Badano, Luigi and Le Tourneau, Thierry and Coisne, Augustin and Modine, Thomas and Praz, Fabien and Zamorano, Jose Luis and von Bardeleben, Ralph Stephan and Hahn, Rebecca T and Fam, Neil and Sievert, Horst and Muraru, Denisa and Adamo, Mariana and Heuts, Samuel and Nejjari, Mohammed and Chan, Vincent and De Bonis, Michele and Carnero-Alcazar, Manuel and Rudolph, Volker and Crestanello, Juan and Lurz, Philipp and Bax, Jeroen and Gauda, Roja and Bernick, Jordan and Wells, George A and Maisano, Francesco and Enriquez-Sarano, Maurice and Bartko, Philipp and Messika-Zeitoun, David and TRIGISTRY Investigators, TRIGISTRY Investigators},
title = {Left Ventricular Ejection Fraction and Benefit of Tricuspid Valve Interventions – Insights from the International TRIGISTRY},
journal = {European Journal of Heart Failure},
year = {2025},
doi = {10.1002/ejhf.3797}
}
EUVIMED